Results 131 to 140 of about 3,323,629 (269)

Prostate Cancer: A State of The Heart [PDF]

open access: yesEuropean Medical Journal Urology, 2014
This symposium was focused on reviewing androgen deprivation therapy (ADT) in prostate cancer, highlighting the implications of this therapy in clinical practice and including a focus on the cardiovascular (CV) risk associated with ADT therapy.
Laurence Klotz   +3 more
doaj  

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

open access: yesExperimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan   +4 more
wiley   +1 more source

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor   +4 more
wiley   +1 more source

Case Report: Abiraterone in brain metastases from prostate cancer

open access: yesFrontiers in Oncology
BackgroundProstate carcinoma (PC) is the most common cancer in men worldwide. However, brain metastases (BM) from prostate cancer are extremely rare events, usually in the later course of the disease.
Tobias Peres   +3 more
doaj   +1 more source

Bones, stones and androgen deprivation therapy [PDF]

open access: yesHormones, 2015
Arrabal-Polo, Miguel Ángel   +2 more
openaire   +3 more sources

Investigating the Effect of Lapatinib on the Performance of Sonodynamic Therapy Against Prostate Cancer via Inhibition of the ABCG2 Efflux System

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 6, December 2026.
ABSTRACT Sonodynamic therapy (SDT) is an emerging site specific and minimally‐invasive modality for cancer treatment. Its efficacy heavily relies on the accumulation and retention of systemically‐administered sensitizing agents within tumor cells.
Yidong Wang   +2 more
wiley   +1 more source

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

open access: yes
BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang   +10 more
wiley   +1 more source

Robot‐Assisted Radical Prostatectomy Using the Hugo RAS System: The First 15 Cases by a First‐Year Novice Surgeon Without Prior Console Experiences

open access: yesThe International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 6, December 2026.
ABSTRACT Background No study has specifically addressed the initial supervised experience of novice surgeons using the Hugo RAS system. Methods We retrospectively reviewed patients with prostate cancer receiving robot‐assisted radical prostatectomy (RARP).
Che‐Hsueh Yang   +7 more
wiley   +1 more source

Long‐term oncological outcomes from a prospective cohort of patients with localised prostate cancer

open access: yesBJU International, Volume 138, Issue 6, Page 1053-1064, December 2026.
Objectives To report long‐term oncological outcomes for men with clinically localised prostate cancer (PCa) treated with contemporary modalities in a population‐based United States cohort. Patients and Methods The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study prospectively enrolled men with clinically localised PCa from ...
Avi S. Baskin   +17 more
wiley   +1 more source

Additional file 1: of Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

open access: yes, 2016
Original data of 290 prostate cancer patients receiving androgen deprivation therapy.
Yinjie Zhu (736022)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy